title: FDG-PET/CT Initial and Subsequent Therapy Evaluation: Progressing to PET/MR Imaging.
abstract: Diagnostic imaging plays an important role in the staging, restaging, and treatment monitoring in head and neck cancer (HNC). MR imaging and computed tomography (CT) are the primary imaging modalities for the assessment of this type of tumor; however, they have been proved to be ineffective in some cases. (18)F-2-fluoro-2-deoxy-D-glucose (FDG) PET/CT and more recently PET/MR imaging are increasingly becoming a standard part of the management of HNC. The purpose of this article is to discuss the indications and benefits of (18)F-FDG PET/CT and PET/MR imaging in the management of patients with HNC.
authors.affiliation: Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H-0250, Stanford, CA 94305, USA.
authors.forename: Camila
authors.initials: C
authors.lastname: Mosci
authors.affiliation: Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H-0250, Stanford, CA 94305, USA.
authors.forename: Guido A
authors.initials: GA
authors.lastname: Davidzon
authors.affiliation: Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H-0250, Stanford, CA 94305, USA. Electronic address: aquon@stanford.edu.
authors.forename: Andrew
authors.initials: A
authors.lastname: Quon